Machine Learning-Driven Pharmacovigilance Models for Drug-Induced Liver Injury (DILI) Risk Prediction and Personalized Therapeutic Dose Optimization in Chronic Liver Disease Patients. The Science Post, [S. l.], v. 2, n. 3, 2026. Disponível em: https://www.thesciencepostjournal.com/index.php/tsp/article/view/254. Acesso em: 26 aug. 2026.